Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Updated time line
View:
Post by jeffm34 on Jan 02, 2022 12:42am

Updated time line

According to the clinical trial website the estimated completion date for the phase 1 trial was March 2022.

https://clinicaltrials.gov/ct2/show/NCT04706962

Now we know part 1 should likely be completed by March 2022. Almost 1 year after they started. Part 2 will involve more patients so we can assume it will take as long or more likely longer than part 1.  So now we are looking at least March 2023 to finish the phase 1 trial which means the trial is already a year behind schedule!

Comment by longterm56 on Jan 02, 2022 8:06am
I think I'll wait to hear from THTX, rather than assume the worst and create fictional schedules without any facts. "Fear, uncertainty, and doubt (often shortened to FUD) is a propaganda tactic used in sales, marketing, public relations, politics, polling and cults. FUD is generally a strategy to influence perception by disseminating negative and dubious or false information and a ...more  
Comment by jfm1330 on Jan 02, 2022 11:30am
Yes, this guy is posting messages with false content. That being said, phase Ia is taking longer than expected, that is clear, but it is false to assume that phase Ib will take as long. Phase Ib will not involve sequential dose escalation. In theory the planned 40 patients could be treated all at the same time with the same dose per body surface area (m2). It will not happen for practical reasons, ...more  
Comment by jfm1330 on Jan 02, 2022 12:09pm
Again, we all knew they were slower than expected in the phase Ia, and now, maybe that reached a higher dose than really expected, or they reached their best case scenario which is three times the MTD of docetaxel alone. All that being said, nothing has changed on the communication timelines. In an article in the Montreal newspaper La Presse on October 13, it is stated this: " ...more  
Comment by jeffm34 on Jan 02, 2022 12:37pm
I guess you don't know anything about clinical trials.  Just like last year when I said we wouldn't see any initial efficacy data from the phase 1 trial until first quarter 2022 at minimum.  You all said we would see some by the middle of 2021.   We are still at least a month (or 2) from part 2 starting. How long do you think it takes to enroll 40 patients?  Throw ...more  
Comment by Wino115 on Jan 02, 2022 2:23pm
I think the oncology centers are generally separate type of facilities.  Some are only oncology centers, some are the oncology soecialization within a larger hospital system. While they can still have staffing issues, I don't think crowded ICUs are an issue for enrollment.  Just the normal Covid issues with patients and staffs.   Without guidance, any timeframe could be ...more  
Comment by jeffm34 on Jan 02, 2022 2:28pm
It's 100% staffing issues right now.  Every facility is struggling to keep basic services open. 
Comment by Wino115 on Jan 02, 2022 2:55pm
Right - seems most severe in midwest, FL and some New England parts right now.  Mid Atlantic a bit too.  Hopefully they will get Cedars Sinai in LA open as a center as that could probably fill half the quota of 1b right there given it's status and population center.   If we get lucky and the path is similar to South Africa, it should start fading in a month or so (although we ...more  
Comment by scarlet1967 on Jan 02, 2022 3:18pm
    I think the pandemic has forced changes to  our ways to get things done. From increasing digital marketing to remote health care and conducting clinical trials among others. They are now suggesting decentralized trials so some information is exchanged through virtual communication and others by home visits. Obviously the pandemic will end at some point but ...more  
Comment by Wino115 on Jan 02, 2022 7:22pm
Glad to know your 3 x vaccinated and kept it to just a mild flu. You're probably right. I guess viruses morph to try to live another day, so milder but more transmissable would be that path. Still hopeful a development like that in future strains and the Paxlovid will convince everyone you can go about your normal routines and just treat yourself with more assurance should one get it.  I ...more  
Comment by scarlet1967 on Jan 02, 2022 8:30pm
Thanks, although early there are some not statistically significant news about omicron will replace Delta eventually I also read elsewhere the immunity in already infected patients with omicron increases the immunity against delta!   https://www.reuters.com/business/healthcare-pharmaceuticals/safrica-study-suggests-omicron-enhances-neutralizing-immunity-against-delta-2021-12-28/    ...more  
Comment by pantonorr on Jan 03, 2022 12:16pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities